SEC Form 4 · accession 0001209191-19-003104
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Berger
Officer — EVP, GEN. COUNSEL & SECRETARY
Period of report
Jan 8, 2019
Accepted (ET)
Jan 9, 2019 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2019 | M | 10,000 | $2.59 | A | 11,765 | D | |
| Common StockF2 | Jan 8, 2019 | S | 10,000 | $40.0751 | D | 1,765 | D | |
| Common StockF3 | holding | — | — | — | 200 | I | Berger Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF4,F5 | $2.59 | Jan 8, 2019 | M | 10,000 | D | — | — | Common Stock | 10,000 | 60,000 | D |
Explanation of responses
- F1Represents shares of common stock received upon exercise of a stock option award.
- F2The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2018, in multiple transactions at prices ranging from $40.00 and $40.15. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- F3Shares are beneficially owned by the Berger Family Trust dated April 16, 2008, for which the Reporting Person is a trustee.
- F4Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter
- F5The expiration date for these options is 10 years from the date of grant.